International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.

ABSTRACT: As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications and international access improves, the volume of HCT performed annually continues to rise. Parallel improvements in HCT techniques and supportive care entails more patients surviving long-term, creating further emphasis on survivorship needs. Survivors are at risk for developing late complications secondary to pre-, peri- and post-transplant exposures and other underlying risk-factors. Guidelines for screening and preventive practices for HCT survivors were originally published in 2006 and updated in 2012. To review contemporary literature and update the recommendations while considering the changing practice of HCT and cellular therapy, an international group of experts was again convened. This revi

SUBMITTER: Rotz SJ 

PROVIDER: S-EPMC11809468 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature